Archimedes Pharma

Archimedes Pharma company information, Employees & Contact Information

Archimedes Pharma is an international specialty pharmaceutical company providing novel and advanced treatments to address unmet needs for people living with serious or life-threatening chronic and debilitating illnesses. Marketing a diverse portfolio of specialty products focused on the oncology, pain, and critical care sectors, Archimedes Pharma has operations in Europe. Founded in 2004, Archimedes Pharma initially acquired a range of specialty products and technologies together with a commercial pharmaceutical platform to establish itself in the European market. Since then the company has expanded its operations to include the in-house development of products based on its proprietary drug delivery technologies. In 2010, Archimedes Pharma attracted significant additional investment to further the company’s growth strategies and build an experienced leadership team, raising approximately $100 million in capital - the largest amount raised by a private European biopharmaceutical company in recent years. Archimedes Pharma has a strong commitment to patients and its customers. By providing novel and technologically advanced therapies, Archimedes Pharma looks to improve current therapeutic approaches and enhance care to patients.

Company Details

Employees
29
Founded
-
Address
250 South Oak Way, Green Park,united States
Phone
441189315051
Email
ti****@****rma.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Reading, UK
Looking for a particular Archimedes Pharma employee's phone or email?

Archimedes Pharma Questions

News

New FDA Actions: Archimedes Pharma's Lazanda - Pharmacy Times

New FDA Actions: Archimedes Pharma's Lazanda Pharmacy Times

FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients - PR Newswire

FDA Approves Lazanda® - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients PR Newswire

Kyowa Hakko Kirin's ProStrakan Acquires Archimedes Pharma for $394M - Genetic Engineering and Biotechnology News

Kyowa Hakko Kirin's ProStrakan Acquires Archimedes Pharma for $394M Genetic Engineering and Biotechnology News

ProStrakan completes acquisition of Archimedes Pharma - BBC

ProStrakan completes acquisition of Archimedes Pharma BBC

CHMP Doles Out Two Positive Opinions on Archimedes Pharma and Merck & Co. Drugs - Genetic Engineering and Biotechnology News

CHMP Doles Out Two Positive Opinions on Archimedes Pharma and Merck & Co. Drugs Genetic Engineering and Biotechnology News

Galashiels firm ProStrakan buys Archimedes Pharma for £230m - BBC

Galashiels firm ProStrakan buys Archimedes Pharma for £230m BBC

Top Archimedes Pharma Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant